Publications by authors named "Maria Arapaki"

Claim this Profile
V
Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.
Maria Dimou, Rodanthi Fioretzaki, Calliope Zerzi, Eliana Konstantinou, John V Asimakopoulos, Maria Arapaki

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bloodstream Infections Due to Multidrug-Resistant Gram-Negative Organisms in Hematopoietic Stem Cell Transplant Recipients: A Multicenter Case-Control Study in a High-Prevalence Area.
Panagiota Palla, Ippokratis Konstantinidis, Zoi Boussiou, Maria Lagkadinou, Ioannis Tsonis, Maria Arapaki

Transplant Cell Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders.
Theodoros P Vassilakopoulos, Fotios Panitsas, Maria Panagiota Arapaki, Amalia Anastasopoulou, Christina Apostolopoulou

Ann Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimally Delivered R-da-EPOCH Versus R-CHOP-21 in Primary Mediastinal Large B-Cell Lymphoma: A Real-Life Comparison in a Single Academic Center.
Alexia Piperidou, Maria K Angelopoulou, Chrysovalantou Chatzidimitriou, John V Asimakopoulos, Maria Arapaki

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.
Evgenia Verrou, Sotirios G Papageorgiou, Maria Bouzani, Aggeliki Sevastoudi, Theodora Triantafyllou, Maria Arapaki

Hematol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Serum β-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients.
Theodoros P Vassilakopoulos, Maria Arapaki, Panagiotis T Diamantopoulos, Athanasios Liaskas, Fotios Panitsas

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version.
Marina Belia, Ioannis Drandakis, Eleftheria Lakiotaki, Maria Arapaki, Fotios Panitsas

Ann Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marrow Iron Stores Are Not Associated with Increased Risk for Invasive Fungal Infections in Patients with Newly Diagnosed Acute Leukemia or Myelodysplastic Syndrome in Transformation: Is There a Relationship?
Eirini A Apostolidi, Maria N Gamaletsou, Maria Arapaki, John V Asimakopoulos, Panagiotis Diamantopoulos

J Fungi (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural fluid overload-associated large B-cell lymphoma with a formerly double-hit genotype.
Athanasios Liaskas, Vasileios Xanthopoulos, Maria Arapaki, Theodoros P Vassilakopoulos

Lancet Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.
Theodoros P Vassilakopoulos, Evrydiki Kravvariti, Fotios Panitsas, Maria K Angelopoulou, Athanasios Liaskas, Maria Arapaki

Blood Cancer J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance.
Stamatios Karakatsanis, Fotios Panitsas, Maria Arapaki, Dimitrios Galopoulos, John V Asimakopoulos

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma.
Chrysovalantou Chatzidimitriou, Phivi Rondogianni, Maria Arapaki, Athanasios Liaskas, Eleni Plata

Medicina (Kaunas)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Theodoros P Vassilakopoulos, Sotirios G Papageorgiou, Maria K Angelopoulou, Sophia Chatziioannou, Vassilios Prassopoulos, Maria Arapaki

Ann Hematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Maria Dimou, Sotirios G Papageorgiou, Niki Stavroyianni, Eirini Katodritou, Maria Tsirogianni, Maria Arapaki

Hematol Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful salvage of primary progressive Hodgkin lymphoma with the combination of post-transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition.
Marina Belia, Chrysovalantou Chatzidimitriou, Phivi Rondogianni, Panayiota Petsa, Maria Efstathopoulou, Maria Arapaki

Hematol Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes.
Sotirios G Papageorgiou, Ioannis Kotsianidis, Anthi Bouchla, Argyris Symeonidis, Athanasios Galanopoulos, Maria Arapaki

Ther Adv Hematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful reversal of severe liver function impairment with Brentuximab vedotin in multiply relapsed/refractory classical Hodgkin lymphoma.
Nikolaos Spathas, Marina Belia, Theofanis Giannikos, Maria Arapaki, Maria Efstathopoulou

J BUON· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies.
Theodoros P Vassilakopoulos, Chrysovalantou Chatzidimitriou, John V Asimakopoulos, Maria Arapaki, Evangelos Tzoras

Cancers (Basel)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.
Maria K Angelopoulou, Eftychia Mosa, Gerassimos A Pangalis, Phoivi Rondogianni, Sofia Chatziioannou, Maria Arapaki

Anticancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis